References
- Aidala, A. A., Wilson, M. G., Shubert, V., Gogolishvili, D., Globerman, J., Rueda, S., Bozack, A. K., Caban, M., & Rourke, S. B. (2016). Housing status, medical care, and health outcomes among people living with HIV/AIDS: A systematic review. American Journal of Public Health, 106(1), e1–e23. https://doi.org/10.2105/AJPH.2015.302905
- Castro, K. G., Ward, J. W., Slutsker, J. W., Jaffe, H. W., & Berkelman, R. L. (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Retrieved December 10, 2017, from www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm
- Cooney, N., Hiransuthikul, N., & Lertmaharit, S. (2015). HIV in young people: Characteristics and predictors for late diagnosis of HIV. AIDS Care, 27(5), 561–569. https://doi.org/10.1080/09540121.2014.986049
- Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253–263. https://doi.org/10.1016/S0376-8716(98)00028-3
- Easterbrook, P. J., Yu, L. M., Goetghebeur, E., Boag, F., McLean, K., & Gazzard, B. (2000). Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS, 14(5), 561–571. https://doi.org/10.1097/00002030-200003310-00012
- Fraser, H., Mukandavire, C., Martin, N. K., Hickman, M., Cohen, M. S., Miller, W. C., & Vickerman, P. (2017). HIV treatment as prevention among people who inject drugs – a re-evaluation of the evidence. International Journal of Epidemiology, 46(2), 466–478. https://doi.org/10.1093/ije/dyw180
- Ghiasvand, H., Higgs, P., Noroozi, M., Ghaedamini Harouni, G., Hemmat, M., Ahounbar, E., Haroni, J., Naghdi, S., Nazeri Astaneh, A., & Armoon, B. (2020). Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: Evidence from a meta-analysis. Biodemography and Social Biology, 65(1), 57–72. https://doi.org/10.1080/19485565.2019.1587287
- Ghiasvand, H., Waye, K. M., Noroozi, M., Harouni, G. G., Armoon, B., & Bayani, A. (2019). Clinical determinants associated with quality of life for people who live with HIV/AIDS: A meta-analysis. BMC Health Services Research, 19(1), 768. https://doi.org/10.1186/s12913-019-4659-z
- Granich, R., Gupta, S., Hersh, B., Williams, B., Montaner, J., Young, B., & Zuniga, J. M. (2015). Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990–2013. PLoS ONE, 10(7), e0131353. https://doi.org/10.1371/journal.pone.0131353
- Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., Gamble, T., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Pilotto, J. H. S., Godbole, S. V., Chariyalertsak, S., de Melo, M. G., Mayer, K. H., … Cohen, M. S. (2014). Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases, 14(4), 281–290. https://doi.org/10.1016/S1473-3099(13)70692-3
- Hayashi, K., Wood, E., Kerr, T., Dong, H., Nguyen, P., Puskas, C. M., Guillemi, S., Montaner, J. S. G., & Milloy, M.-J. (2016). Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: A prospective cohort study. BMC Infectious Diseases, 16(1), 455. https://doi.org/10.1186/s12879-016-1749-y
- Kennedy, M. C., Kerr, T., McNeil, R., Parashar, S., Montaner, J., Wood, E., & Milloy, M.-J. (2017). Residential eviction and risk of detectable plasma HIV-1 RNA viral load among HIV-positive people who use drugs. AIDS and Behavior, 21(3), 678–687. https://doi.org/10.1007/s10461-016-1315-z
- Lappalainen, L., Hayashi, K., Dong, H., Milloy, M. J., Kerr, T., & Wood, E. (2015). Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy. Addiction, 110(1), 111–119. https://doi.org/10.1111/add.12736
- Maas, B., Fairbairn, N., Kerr, T., Li, K., Montaner, J. S. G., & Wood, E. (2007). Neighborhood and HIV infection among IDU: Place of residence independently predicts HIV infection among a cohort of injection drug users. Health & Place, 13(2), 432–439. https://doi.org/10.1016/j.healthplace.2006.05.005
- Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242–1257. https://doi.org/10.1111/j.1360-0443.2008.02269.x
- Marshall, B. D. L., Elston, B., Dobrer, S., Parashar, S., Hogg, R. S., Montaner, J. S. G., Kerr, T., Wood, E., & Milloy, M.-J. (2016). The population impact of eliminating homelessness on HIV viral suppression among people who use drugs. AIDS, 30(6), 933–942. https://doi.org/10.1097/QAD.0000000000000990
- McNeil, R., Kerr, T., Coleman, B., Maher, L., Milloy, M. J., & Small, W. (2017). Antiretroviral therapy interruption among HIV positive people who use drugs in a setting with a community-wide HIV treatment-as-prevention initiative. AIDS and Behavior, 21(2), 402–409. https://doi.org/10.1007/s10461-016-1470-2
- Miller, C. L., Tyndall, M., Spittal, P., Li, K., Palepu, A., & Schechter, M. T. (2002). Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health : Bulletin of the New York Academy of Medicine, 79(2), 257–265. https://doi.org/10.1093/jurban/79.2.257
- Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., Montaner, J., & Wood, E. (2012). Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care and STDs, 26(1), 60–67. https://doi.org/10.1089/apc.2011.0169
- Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., Montaner, J., & Wood, E. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. The Journal of Infectious Diseases, 203(9), 1215–1221. https://doi.org/10.1093/infdis/jir032
- Milloy, M.-J., Montaner, J., & Wood, E. (2012). Barriers to HIV treatment among people who use injection drugs: Implications for “treatment as prevention”. Current Opinion in HIV and AIDS, 7(4), 332–338. https://doi.org/10.1097/COH.0b013e328354bcc8
- Milloy, M.-J., Wood, E., Kerr, T., Hogg, B., Guillemi, S., Harrigan, P. R., & Montaner, J. (2016). Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide treatment-as-prevention initiative. Clinical Infectious Diseases, 62(5), 640–647. https://doi.org/10.1093/cid/civ929
- Nosyk, B., Lourenco, L., Min, J. E., Shopin, D., Lima, V. D., & Montaner, J. S. G. (2015). Characterizing retention in HAART as a recurrent event process: Insights into “cascade churn”. AIDS, 29(13), 1681–1689. https://doi.org/10.1097/QAD.0000000000000746
- Nosyk, B., Min, J., Lima, V. D., Yip, B., Hogg, R. S., & Montaner, J. S. G. (2013). HIV-1 disease progression during highly active antiretroviral therapy: An application using population-level data in British Columbia: 1996–2011. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63(5), 653–659. https://doi.org/10.1097/QAI.0b013e3182976891
- Nosyk, B., Zang, X., Min, J. E., Krebs, E., Lima, V. D., Milloy, M.-J., Shoveller, J., Barrios, R., Harrigan, P. R., Kerr, T., Wood, E., & Montaner, J. S. G. (2017). Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: A modelling study. The Lancet HIV, 4(7), e303–e310. https://doi.org/10.1016/S2352-3018(17)30045-0
- Obel, N., Omland, L. H., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Sørensen, H. T., Gerstoft, J., & Myer, L. (2011). Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: A population-based nationwide cohort study. PLOS ONE, 6(7), e22698. https://doi.org/10.1371/journal.pone.0022698
- Poorolajal, J., Hooshmand, E., Mahjub, H., Esmailnasab, N., & Jenabi, E. (2016). Survival rate of AIDS disease and mortality in HIV-infected patients: A meta-analysis. Public Health, 139, 3–12. https://doi.org/10.1016/j.puhe.2016.05.004
- Pouget, E. R., West, B. S., Tempalski, B., Cooper, H. L. F., Hall, H. I., Hu, X., & Friedman, S. R. (2014). Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007. Public Health Reports, 129(3), 267–279. https://doi.org/10.1177/003335491412900309
- Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., Justice, A., Kirk, G., Klein, M. B., Korthuis, P. T., Martin, J., Napravnik, S., Rourke, S. B., Sterling, T. R., Silverberg, M. J., … Okulicz, J. F. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLOS ONE, 8(12), e81355. https://doi.org/10.1371/journal.pone.0081355
- Schwarcz, L., Chen, M.-J., Vittinghoff, E., Hsu, L., & Schwarcz, S. (2013). Declining incidence of AIDS-defining opportunistic illnesses. AIDS, 27(4), https://doi.org/10.1097/QAD.0b013e32835b0fa2
- Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010). HIV and risk environment for injecting drug users: The past, present, and future. Lancet (London, England), 376(9737), 268–284. https://doi.org/10.1016/S0140-6736(10)60743-X
- Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O’Shaughnessy, M. V., Montaner, J. S., Schechter, M. T., & Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280(6), 547–549. https://doi.org/10.1001/jama.280.6.547
- Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M. L., Montaner, J. S. G., Schechter, M. T., & O'Shaughnessy, M. V. (1997). Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS, 11(8), F59–F65. https://doi.org/10.1097/00002030-199708000-00001
- UNAIDS. (2017). Ending AIDS: Progress towards the 90–90–90 targets (No. JC2900E).
- West, B. S., Pouget, E. R., Tempalski, B., Cooper, H. L. F., Hall, H. I., Hu, X., & Friedman, S. R. (2015). Female and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007. Annals of Epidemiology, 25(4), 218–225. https://doi.org/10.1016/j.annepidem.2015.01.006
- WHO. (2016). Global health estimates 2015: Deaths by cause, age, sex, by Country and by Region, 2000–2015.